CC

CC

USD

Chemours Company (The) Common Stock

$12.370+0.120 (0.980%)

Reaalajas hind

Põhimaterjalid
Erikemikaalid
Ameerika Ühendriigid

Hinnagraafik

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$12.250

Kõrge

$12.450

Madal

$12.150

Maht

0.03M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

1.9B

Tööstusharu

Erikemikaalid

Riik

United States

Kauplemisstatistika

Keskmine maht

3.05M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $9.33Praegune $12.370Kõrge $29.21

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 23. apr 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

CC: Chemours Company (The) Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: CC Generate Date: 2025-04-23 15:36:17

Alright, let's take a look at what's been going on with Chemours Company stock, ticker symbol CC. We'll break down the recent news, check out the price chart, and see what some of the data points might be telling us.

The Latest Buzz: News & Sentiment

What's the talk around Chemours lately? Well, it's a bit of a mixed bag, but with some recent positive energy showing up in the data.

We know the company has an earnings report coming up on May 6th. That's a standard announcement, but earnings reports are always a big deal and can really move the stock depending on the results. So, mark that date if you're watching CC.

On the analyst front, we saw two different calls recently. Barclays lowered their price target on April 1st, moving it from $19 down to $16 while keeping an "Equal-Weight" rating. That's not exactly a vote of confidence.

However, just a few days before that, on March 27th, Mizuho upgraded Chemours from "Neutral" to "Outperform" and kept their price target at $19. An upgrade like that usually signals a more positive view from that analyst firm.

Putting these together, you have one analyst getting a bit less optimistic while another is getting more optimistic. The overall sentiment data we have leans positive, suggesting the market might be paying more attention to the upgrade and other positive signals right now.

Checking the Price Chart: What's Happened?

Looking back over the last few months, the price action for CC has been pretty dramatic. The stock was trading up around the $19-$20 mark back in late January. From there, it went through a significant decline, hitting a low point just above $9 in early April. That's a big drop!

But here's where it gets interesting: since hitting that low, the stock has bounced back noticeably. Today, it's trading around $12.68. This recent move up shows some real buying interest has returned after that steep fall. The trading volume has also picked up during this bounce, which often adds conviction to a price move.

Comparing the current price to the AI's prediction data, the AI model is projecting an upward trend and sees a potential target price quite a bit higher, around $17.49. This aligns with the recent positive price momentum we've seen.

Putting It All Together: What Might This Mean?

So, what does this mix of news, price action, and data suggest for Chemours in the near term?

Based on the recent strong bounce in the stock price, the positive analyst upgrade from Mizuho, the generally positive sentiment score, and the AI's prediction of an upward trend, the situation seems to be leaning towards a potential positive outlook right now, at least in the short term.

It looks like the stock might be trying to recover after being heavily sold off. The technical indicators mentioned in the data, like the MACD "golden cross" and increased buying volume, support this idea of recent bullish momentum.

However, it's super important to remember the bigger picture. The company operates in Specialty Chemicals and Basic Materials. The fundamental data points out some challenges, specifically high debt levels and negative revenue growth. These are significant risk factors that explain why the stock is considered high risk and suitable for aggressive investors. This isn't a 'set it and forget it' situation; it requires careful watching.

Thinking About Potential Next Steps (Cautiously)

If you're considering this stock, here are some ideas based on the data, but remember this isn't advice – just an interpretation:

  • Potential Entry: The recommendation data suggested entry points around $11.98 and $12.06. The stock has already moved above those levels with the recent bounce. One approach might be to watch if the stock pulls back slightly towards that $12 area, which was also noted as a support level, to see if it holds. Another might be to see if it can break convincingly above the short-term take-profit level mentioned below, which could signal continued strength.
  • Managing Risk (Stop-Loss): The data suggests a stop-loss level at $10.85. This level is below recent significant lows and acts as a point to consider exiting the position to limit potential losses if the recent positive momentum fails and the stock starts heading back down. Having a plan to manage risk is crucial, especially with a stock flagged as high risk.
  • Potential Targets (Take-Profit): For the short-term (1-2 weeks), the data points to a take-profit level around $12.98. This is just above the current price and represents a potential area to consider taking some profits if the bounce continues. Looking further out, the AI's potential target of $17.49 is much higher, suggesting there might be significant room for recovery if the positive trend persists, but reaching that level would likely take more time and depend heavily on future company performance and market conditions, including that upcoming earnings report.

Company Snapshot

Just a quick reminder about Chemours: they make various chemicals, from refrigerants (Freon, Opteon) to the white pigment used in paints and plastics (Ti-Pure) and performance materials (Teflon, Viton). Their business performance is tied to demand in industries that use these products. The high debt mentioned earlier is a key financial point to be aware of.


Disclaimer: This analysis is based on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves significant risk, and you could lose money. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Seotud uudised

BusinessWire

Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call

The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2025 financial results after market on Tuesday, May 6, 2025. The Company expects to hold

Vaata rohkem
Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call
Analyst Upgrades

Barclays Maintains Equal-Weight on Chemours, Lowers Price Target to $16

Barclays analyst Michael Leithead maintains Chemours with a Equal-Weight and lowers the price target from $19 to $16.

Vaata rohkem
Barclays Maintains Equal-Weight on Chemours, Lowers Price Target to $16
Analyst Upgrades

Mizuho Upgrades Chemours to Outperform, Maintains Price Target to $19

Mizuho analyst John Roberts upgrades Chemours from Neutral to Outperform and maintains the price target from $19 to $19.

Vaata rohkem
Mizuho Upgrades Chemours to Outperform, Maintains Price Target to $19

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 28. apr 2025, 05:55

LangevNeutraalneTõusev

63.9% Kindlus

Risk ja kauplemine

Riskitase4/5
Kõrge risk
Sobib
Agressiivne
Kauplemisjuhend

Sisenemispunkt

$12.26

Võta kasum

$13.33

Peata kahjum

$11.13

Põhitegurid

PDI 14.1 on MDI 7.9 kohal ADX-iga 11.5, mis viitab tõusutrendile
Praegune hind on tugitasemele ($12.27) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 6.5x keskmisest (31,692), mis viitab äärmiselt tugevale ostusurvele
MACD 0.0114 on signaalijoone -0.0018 kohal, mis viitab tõusvale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.